The ability of tumor volume to predict relative risks of local failure associated with surgical and non-surgical treatment of supraglottic carcinoma

Asian Oceanian Journal of Radiology

Volumn 6, Issue 1, 2001, Pages 13-20

  Mukherji, S K ^a   Mancuso, A A ^a   O'Brien, S ^a   Mendenhall, W ^a   Weissler, M ^a   Pillsbury, H C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Risks of surgical and non surgical treatment; Supraglottic carcinoma; Tumour volume

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; LARYNX CARCINOMA; LARYNX SURGERY; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ASSAY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

EID: 0035059831     PISSN: 09722688     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Squamous cell carcinoma of the supraglottic larynx treated with radical irradiation: Analysis of treatment parameters and results
2. Squamous cell carcinoma of the supraglottic larynx treated with surgery and' or radiation therapy
3. Optimal treatment for the technically resectable squamous cell carcinoma of the supraglottic larynx
4. CT scanning as an aid to selection of therapy in T2-T4 laryngeal cancer
5. Supraglottic laryngectomy for intermediate-stage cancer: UTMD Anderson Cancer Center experience with combined therapy
6. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx
7. The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx
8. Causes of failure in irradiation of squamous-cell carcinoma of the supraglottic larynx
9. Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve
10. Larynx
11. Larynx and hypopharynx
12. Supraglottic laryngectomy
13. Larynx
14. Imaging squamous cell carcinomas of the upper aerodigestive tract: What the clinicians need to know
15. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome
16. The tumor volume and clonogen number relationship: Tumor control predictions based upon tumor estimates derived from computed tomography
17. Preradiotherapy-computed tomography as a predictor of local control in supraglottic carcinoma
18. Irradiation alone for supraglottic larynx carcinoma: Can CT findings predict treatment results?
19. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy?
20. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinomas of the glottic larynx treated with radiotherapy alone?
21. Correlation of tumor volume with local control in laryngeal carcinoma treated by radiotherapy
22. Tumor volume: An independent predictor of outcome for laryngeal cancer
23. Tumor volume as a predictor of local control in patients with laryngeal cancer treated surgically
24. Predicting the local control of glottic squamous cell carcinoma after definitive radiation therapy: Value of computed tomography-determined tumour parameters
25. The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx
26. Irradiation alone for supraglottic larynx carcinoma: Can CT findings predict treatment results?
27. Larynx preservation in pyriform sinus cancer: Preliminary results of a European organisation for research and treatment of cancer Phase III trial
28. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study group
29. Radiologic appearance of the irradiated larynx. Part I. Expected changes
30. Radiologic appearance of the irradiated larynx Part II. Primary site response
31. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer
32. The promise FDG in diagnosis and surveillance of head and neck cancer
33. Variability of laryngeal tumor volume measurements determined with CT
34. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma
35. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro
36. High frequency of p16 (CDKN2/MTS1/INK4A) inactivation in head and neck squamous cell carcinoma
37. Selective radiosensitization of p53 deficient cells by caffeine-mediated activation of p34cdc2 kinase